期刊文献+

高甲状腺素模型心室组织中血管紧张素转化酶及血管紧张受体的表达 被引量:3

Expression of angiotensin converting enzyme,angiotensin Ⅱ receptor 1,and angiotensin Ⅱ receptor 2 in rabbits with hyperthyroid cardiomyopathy
下载PDF
导出
摘要 目的研究甲状腺功能亢进(简称甲亢)性心肌病兔心室组织血管紧张素转化酶(ACE)及血管紧张受体表达,探讨甲亢性心肌病的发病机制。方法健康成年新西兰大白兔40只,随机分为4组:对照组,左旋甲状腺素(L-thy)组,咪哒普利组(L-Thy+I midapril),缬沙坦组(L-Thy+Valsartan)。L-Thy[45μg/(kg.d)×28 d]腹腔注射建立甲亢动物模型,测定左右心室心肌肥厚指数、心肌细胞直径,Masson′s染色测定胶原容积分数,放免法检测血浆及组织血管紧张素Ⅱ(AngⅡ)浓度,RT-PCR半定量检测ACE、血管紧张素受体1(AT1R)、血管紧张素受体2(AT2R)mRNA表达,Western blot检测ACE、AT1R、AT2R蛋白表达。结果 L-Thy可诱导心肌肥厚及心肌纤维化,血浆与局部组织AngⅡ浓度升高,ACE mRNA及蛋白表达上调,AT1R、AT2R mR-NA及蛋白表达上调。咪哒普利和缬沙坦均可显著抑制L-Thy诱导的心肌细胞肥厚和纤维化,咪哒普利可降低血浆与局部心肌组织AngⅡ水平,对AT1R、AT2R和ACE的表达无影响。缬沙坦显著升高血浆AngⅡ浓度,但不升高组织AngⅡ浓度;且显著上调AT1R、AT2R mRNA表达,对ACE的表达无影响。结论甲亢性心肌病兔有循环和组织AngⅡ浓度升高,AT1R、AT2R和ACE表达上调,肾素-血管紧张素系统(RAS)可能参与甲亢性心肌病的发病机制。咪哒普利和缬沙坦可以改善L-Thy诱导的心肌重构。 Objective To study the expression of angiotensin converting enzyme(ACE),angiotensin Ⅱ receptor 1(AT1R),and angiotensin Ⅱ receptor 2(AT2R) in rabbits with hyperthyroid cardiomyopathy induced by levothyroxine(L-Thy).Methods A rabbit model of hyperthyroidism was established by daily intraperitoneal injections of L-Thy(45μg/kg per day,28 d).Forty New Zealand rabbits were randomly divided into fours groups:control group(n=10),L-Thy group(L-Thy only,n=10),imidapril group(L-Thy+ imidapril,n=10),and valsartan group(L-Thy+valsartan,n=10).Ventricular tissues were collected at 4 weeks.Cardiac hypertrophy index and cardiomyocyte diameter were detected.Cardiac fibrosis was displayed by Masson′s stain and collegen volume fraction(CVF)was measured using pathological image analytic system.Plasm and cardiac angiotensin Ⅱ concentration were measured with radioimmunoassays(RIAs).mRNA expression of ACE,AT1R,and AT2R were semi-quantified with RT-PCR.Expression of ACE,AT1R,and AT2R protein was evaluated with Western blot analysis.Results Compared with control group,rabbits merely treated with L-Thy displayed remarkable myocardial hypertrophy and extracellular matrix fibrosis.Increased plasm and tissue AngⅡ was detected in L-Thy group.RT-PCR and Western blot analysis revealed enhanced mRNA and protein expression of ACE,AT1R,and AT2R.Our study demonstrated that both imidapril and valsartan alleviated cardiomyocyte hypertrophy and extracellular matrix fibrosis induced by L-Thy.Compared with L-Thy and valsartan group,imidapril group showed significantly lower plasm /tissue AngⅡ concentration and more effective inhibition of extracellular matrix fibrosis.Imidapril did not alter expression of ACE,AT1R,and AT2R.Plasm concentration of AngⅡ was markedly higher in valsartan group compared with L-Thy group,whereas tissue AngⅡ concentration was not significantly different between the two groups.In valsartan group,AT1R and AT2R mRNA expressions were significantly upregulated,whereas valsartan did not change expression of ACE.Conclusion Expression of ACE,AT1R,and AT2R is upregulated in rabbits with hyperthyroid cardiomyopathy induced by L-Thy.Renin-angiotension system(RAS)may play important role in hyperthyroid cardiomyopathy.Imidapril and valsartan may exert benefical effects on hyperthyroid cardiomyopathy via improring myocardial remodeling.
出处 《重庆医学》 CAS CSCD 北大核心 2010年第18期2413-2416,共4页 Chongqing medicine
关键词 甲状腺功能亢进 心肌病 肾素-血管紧张素系统 hyperthyrodism cardiomyopathy renin-angiotensin system
  • 相关文献

参考文献16

  • 1Biondi B,Palmieri EA,Lombardi G,et al.Effects of thyroid hormone on cardiac function:the relative importance of heart rate,loading conditions,and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism[J].J Clin Endocrinol Metab,2002,87(3):968.
  • 2Kobori H,Hayashi M,Saruta T.Thyroid Hormone Stimulates Renin Gene Expression Through the Thyroid Hormone Response Element[J].Hypertension,2001,37(1):99.
  • 3Biondi B,Fazio S,Carella C,et al.Control of adrenergic overactivity by beta-blokade improve the quality of life in patient receiving long term suppressive therapy with levothyroxine[J].J Clin Endocrinol Meta,1994,78:1028.
  • 4Irwin K,Kaie O.Thyroid hormone and the cardiovascular system[J].N Engl J Med,2001,344:501.
  • 5Van Kats JP,Danser AH,Van Meegen J,et al.Angiotensin production by the heart:a quantitative study in pigs with the use of radiolabeled angiotensin infusions[J].Circulation,1998,98:73.
  • 6Wolny A,Clozel JP,Rein J,et al.Function and biochemical analysis of angiotensin Ⅱ-forming pathway in the human heart[J].Circ Res,1997,80:219.
  • 7De Mello WC,Jan Denser AH.Angiotensin and the heart on the intracrine RAS[J].Hypertension,2000,35(6):1183.
  • 8Liu YH,Yang XP,Sharov V,et al.Effects of angiotensin-converting enzyme inhibitors and angiotensin Ⅱ type 1 receptor antagonists in rats with heart failure:role of kinins and angiotensin Ⅱ type 2 receptors[J].J Clin Invest,1997,99:1926.
  • 9Brewster UC,Setaro JF,Perazella MA.The renin-angiotensin-aldosterone system:cardiorenal effects and implications for renal and cardiovascular disease states[J].Am J Med Sci,2003,326(1):15.
  • 10Gonzalez A,Lopez B,Diez J.Fibrosis in hypertensive heart disease:role of the renin-angiotensin-aldosterone system[J].Med Clin North Am,2004,88(1):83.

同被引文献82

  • 1姜秀春,姜秀丽,李树青.心肌纤维化发病机制和防治的研究进展[J].医学综述,2006,12(15):931-933. 被引量:18
  • 2韩瑜,韩变梅,柳明洙,陈曦.心肌胶原及代谢[J].中国循环杂志,2006,21(4):315-317. 被引量:13
  • 3张安,邓武,殷跃辉.甲亢性心肌病兔心肌血管紧张素转换酶和细胞外信号调节激酶的变化[J].第三军医大学学报,2007,29(22):2156-2159. 被引量:4
  • 4Katircibasi MT,Deniz F,Pamukcu B. Effects of short-term propylthiouracil treatment on p wave duration and p wave dispersion in patients with overt hyperthyroidism[J].Experimental and Clinical Endocrinology & Diabetes,2007,(06):376-379.
  • 5Frost L,Vestergaard P. Alcohol and risk of atrial fibrillation or flutter:a cohort study[J].Archives of Internal Medicine,2004,(18):1993-1998.doi:10.1001/archinte.164.18.1993.
  • 6Santos RA,Ferreira AJ,Verano-Braga T. Angiotensin-converting enzyme 2,angiotensin-(1-7) and Mas:new players of the renin-angiotensin system[J].Journal of Endocrinology,2013,(02):1-17.
  • 7谌贻璞.肾脏在维持正常人体血压中的作用[M]北京:人民卫生出版社,20081625-1630.
  • 8Fyhrquist F,Saijonmaa O. Renin-angiotensin system revisited[J].Internal Medicine,2008,(03):224-236.
  • 9Irwin K,Kale O. Thyroid hormone and the cardiovascular system[J].New England Journal of Medicine,2001,(07):501-509.
  • 10Van Dijk-Ottens M,Vos IH,Cornelissen PW. Thyroid hormone-induced cardiac mechano growth factor expression depends on beating activity[J].Endocrinology,2010,(02):830-838.doi:10.1210/en.2009-0520.

引证文献3

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部